Ulrich Dietmar, Lichtenegger Franziska, Unglaub Frank, Smeets Ralf, Pallua Norbert
Department of Plastic Surgery and Hand Surgery, Burn Center, University Hospital, Aachen University of Technology, Aachen, Germany.
Plast Reconstr Surg. 2005 Aug;116(2):539-45. doi: 10.1097/01.prs.0000173447.81513.7a.
New evidence suggests that matrix metalloproteinases (MMPs) may facilitate angiogenesis as well as function to generate angiogenesis inhibitors. In this study, the angiogenic effect of wound exudates from patients with venous insufficiency ulcers was examined in an in vitro angiogenesis model with and without synthetic MMP-2/-9 inhibitor.
Wound exudates were obtained from 20 patients with venous insufficiency ulcers and 20 control patients with donor-site wounds after skin grafting for burns. In the angiogenesis model, suramin (20 microg/ml) was used in five wells without wound fluid as negative control, and vascular endothelial growth factor (1 microg/ml) was used in five other wells as positive control. Chronic wound fluids were analyzed without and with a synthetic MMP-2/-9 inhibitor with a concentration of 2 microM and 20 microM in the medium. The total length of tubules was calculated by map reader. Statistical analysis was performed using the Mann-Whitney test. The level of significance was considered to be p < 0.05.
Chronic ulcer exudates inhibited angiogenesis significantly (490 +/- 130 microm) compared with acute wound fluids (1740 +/- 320 microm; p < 0.05). In wells with chronic wound exudates and high concentrations of MMP-2/-9 inhibitor, angiogenesis was stimulated significantly (870 +/- 220 microm, p < 0.05).
In this model, reduced angiogenesis might be due to an antiangiogenic effect of MMP-2 and MMP-9. MMP-2/-9 inhibition results in a stimulation of angiogenesis and might be an approach for the treatment of patients with chronic wounds and reduced angiogenesis.
新证据表明,基质金属蛋白酶(MMPs)可能促进血管生成,同时也具有生成血管生成抑制剂的功能。在本研究中,在有和没有合成MMP-2/-9抑制剂的体外血管生成模型中,检测了静脉功能不全溃疡患者伤口渗出液的血管生成作用。
从20例静脉功能不全溃疡患者和20例烧伤皮肤移植后供皮区伤口的对照患者中获取伤口渗出液。在血管生成模型中,5个孔中使用苏拉明(20微克/毫升)作为无伤口液体的阴性对照,另外5个孔中使用血管内皮生长因子(1微克/毫升)作为阳性对照。在培养基中分别添加浓度为2微摩尔和20微摩尔的合成MMP-2/-9抑制剂,分析慢性伤口液体有无抑制剂时的情况。通过图像分析软件计算小管的总长度。采用Mann-Whitney检验进行统计分析。显著性水平设定为p < 0.05。
与急性伤口液体(1740±320微米)相比,慢性溃疡渗出液显著抑制血管生成(490±130微米;p < 0.05)。在含有慢性伤口渗出液和高浓度MMP-2/-9抑制剂的孔中,血管生成受到显著刺激(870±220微米,p < 0.05)。
在该模型中,血管生成减少可能是由于MMP-2和MMP-9的抗血管生成作用。抑制MMP-2/-9可刺激血管生成,这可能是治疗慢性伤口和血管生成减少患者的一种方法。